Case number 1:19-cv-00811
Arena Pharmaceuticals, Inc. et al v. Aurobindo Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 16, 2020 | 38 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,953,787 B2; 7,514,422 B2; 7,977,329 B2; 8,207,158 B2; 8,273,734 B1; 9,770,455 B2. (Attachments: # (1) Order)(nms) |
| Mar 16, 2020 | 38 | Order (2) |
| Mar 16, 2020 | 38 | Patent/Trademark Report to Commissioner (1) |
| Mar 13, 2020 | 37 | Order (2) Docket Text: SO ORDERED Granting [36] Stipulation and Order of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 3/12/2020. (nms) |
| Mar 12, 2020 | 36 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal, by 356 Royalty Inc., Arena Pharmaceuticals, Inc., Eisai Inc.. (Raucci, Anthony) Modified on 3/12/2020 (nms). |
| Feb 10, 2020 | 35 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Initial Invalidity Contentions filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jan 9, 2020 | 34 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding request that the May 5, 2020 Markman hearing and the interim deadlines for claim construction briefing be cancelled. (Blumenfeld, Jack) |
| Jan 6, 2020 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by 356 Royalty Inc., Arena Pharmaceuticals, Inc., Eisai Inc..(Raucci, Anthony) |
| Dec 9, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: In light of the email on behalf of Aurobindo with the redline attachment, counsel shall provide by email to Judge Thynge, with a copy to Ms. Kennedy, a joint update regarding their negotiations on or before close of business 1/6/20. To the extent either side believes that confidential information may be required to fully respond to this Oral Order, counsel may also provide a separate, private email to Judge Thynge, with a copy to Ms. Kennedy, and/or request a date/time for a teleconference with Judge Thynge. Ordered by Judge Mary Pat Thynge on 12/9/19. (cak) |
| Dec 5, 2019 | 31 | Order (24) Docket Text: SO ORDERED Granting [30] Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 12/5/2019. (nms) |
| Dec 4, 2019 | 30 | Proposed Order (24) Docket Text: PROPOSED Stipulated Protective Order, by 356 Royalty Inc., Arena Pharmaceuticals, Inc., Eisai Inc.. (Raucci, Anthony) Modified on 12/5/2019 (nms). |
| Nov 25, 2019 | N/A | Oral Order (0) |
| Nov 21, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [28] STIPULATION and Order Extending Deadline. Signed by Judge Richard G. Andrews on 11/21/2019. (nms) |
| Nov 20, 2019 | 28 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Order Extending Deadline - filed by 356 Royalty Inc., Arena Pharmaceuticals, Inc., Eisai Inc.. (Raucci, Anthony) Modified on 11/21/2019 (nms). |
| Nov 20, 2019 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Aurobindo's response to Plaintiffs' First Set of Interrogatories (Nos. 1-9); (2) Aurobindo's response to Plaintiffs' First Set of Requests for Production (Nos. 1-55); and (3) Aurobindo's response to Plaintiffs' First Set of Requests for Admission (Nos. 1-18) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Nov 7, 2019 | N/A | SO ORDERED (0) |
| Nov 6, 2019 | 26 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to November 20, 2019 - filed by 356 Royalty Inc., Arena Pharmaceuticals, Inc., Eisai Inc.. (Blumenfeld, Jack) |
| Nov 5, 2019 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Defense counsel to initiate the call. A Telephone Conference is set for 11/22/2019 at 9:00 AM with Judge Mary Pat Thynge to follow up regarding mediation. Ordered by Judge Mary Pat Thynge on 11/5/19. (cak) |
| Oct 31, 2019 | N/A | SO ORDERED (0) |
| Oct 30, 2019 | 24 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Regarding Custodians and Non-Custodial Data Sources; and (2) Plaintiffs' Initial Disclosures Identifying Aurobindo's Accused Product and Plaintiffs' Asserted Patents filed by 356 Royalty Inc., Arena Pharmaceuticals, Inc., Eisai Inc..(Raucci, Anthony) |
| Oct 30, 2019 | 23 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to November 6, 2019 - filed by 356 Royalty Inc., Arena Pharmaceuticals, Inc., Eisai Inc.. (Raucci, Anthony) Modified on 10/31/2019 (nms). |
| Oct 30, 2019 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Paragraph 3 Disclosures filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Oct 15, 2019 | N/A | Order Setting Teleconference (0) |
| Oct 7, 2019 | 20 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Rule 26(a)(1) Initial Disclosures; (2) Plaintiffs' First Set of Requests for Production of Documents and Things from Aurobindo (Nos. 1-55); (3) Plaintiffs' First Set of Interrogatories (Nos. 1-9); and (4) Plaintiffs' First Set of Requests for Admission (Nos. 1-18) filed by 356 Royalty Inc., Arena Pharmaceuticals, Inc., Eisai Inc..(Blumenfeld, Jack) |
| Oct 7, 2019 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial disclosures pursuant to FRCP 26(a) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Oct 1, 2019 | 18 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 10/11/2019 at 11:00 AM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 10/1/19. (cak) |
| Sep 30, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Sep 30, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The order filed at D.I. 18 has been removed as it was filed in error. (nms) |
| Sep 30, 2019 | 16 | Scheduling Order (7) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/13/2020. Amended Pleadings due by 3/13/2020. Discovery due by 7/10/2020. Joint Claim Construction Brief due by 4/3/2020. A Markman Hearing is set for 5/5/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 4/16/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 4/21/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 9/30/2019. (nms) |
| Sep 30, 2019 | N/A | Oral Order (0) |
| Sep 27, 2019 | 15 | cover letter (1) |
| Sep 27, 2019 | 15 | Main Document (7) Docket Text: PROPOSED Scheduling Order, by Eisai Inc.. (Attachments: # (1) Letter)(Raucci, Anthony) Modified on 9/27/2019 (nms). |
| Sep 27, 2019 | 15 | Proposed Order (7) |
| Sep 26, 2019 | 14 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David A. Chen - filed by 356 Royalty Inc., Arena Pharmaceuticals, Inc., Eisai Inc.. (Raucci, Anthony) |
| Sep 26, 2019 | N/A | SO ORDERED (0) |
| Sep 25, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Melanie R. Rupert for 356 Royalty Inc., for Arena Pharmaceuticals, Inc., for Eisai Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Sep 25, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Sep 25, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Sep 11, 2019 | 13 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Young J. Park and Melanie R. Rupert - filed by 356 Royalty Inc., Arena Pharmaceuticals, Inc., Eisai Inc.. (Raucci, Anthony) |
| Sep 11, 2019 | N/A | SO ORDERED (0) |
| Sep 10, 2019 | 12 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 10/2/2019, at 10:30 AM in Chambers before Judge Richard G. Andrews (see order for further details). Signed by Judge Richard G. Andrews on 9/10/2019. (nms) |
| Sep 3, 2019 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma U.S.A., Inc. for Aurobindo Pharma Limited filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Sep 3, 2019 | 10 | Answer to Complaint (18) Docket Text: ANSWER to [1] Complaint, by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Aug 20, 2019 | N/A | SO ORDERED (0) |
| Aug 19, 2019 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to September 3, 2019 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) Modified on 8/20/2019 (nms). |
| Jul 31, 2019 | 8 | Affidavit of Service (10) Docket Text: AFFIDAVIT of Service for Complaint and related documents served on Aurobindo Pharma Limited on July 31, 2019, filed by 356 Royalty Inc., Arena Pharmaceuticals, Inc., Eisai Inc.. (Blumenfeld, Jack) |
| Jul 30, 2019 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Arena Pharmaceuticals, Inc., 356 Royalty Inc., Eisai Inc.. Aurobindo Pharma USA, Inc. served on 7/30/2019, answer due 8/20/2019. (Blumenfeld, Jack) |
| May 8, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| May 1, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. on 5/1/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (amf) |
| May 1, 2019 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eisai Co., Ltd. for Eisai Inc. - filed by Eisai Inc. (amf) |
| May 1, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Arena Pharmaceuticals, Inc. for 356 Royalty Inc. - filed by 356 Royalty Inc. and Arena Pharmaceuticals, Inc. (amf) |
| May 1, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,953,787 B2 ;7,514,422 B2; 7,977,329 B2; 8,207,158 B2; 8,273,734 B1; and 9,770,455 B2. (amf) |
| May 1, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/20/2019. Date of Expiration of Patent: See attached form.Thirty Month Stay Deadline: 9/20/2021. (amf) |
| May 1, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf) |
| May 1, 2019 | 1 | Civil Cover Sheet (1) |
| May 1, 2019 | 1 | Main Document (13) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2632513) - filed by Arena Pharmaceuticals, Inc., 356 Royalty Inc., and Eisai Inc. (Attachments: # (1) Exhibits A-F, # (2) Civil Cover Sheet)(amf) |
| May 1, 2019 | 1 | Exhibits A-F (318) |
| May 1, 2019 | 1 | Complaint (13) |
| May 1, 2019 | 1 | Complaint* (1) |
